World's Best Scientists 2026 revealed!
Karel Pavelka

Karel Pavelka

Award Badge
Medicine
Czechia
2023

D-Index & Metrics

Medicine

D-Index
86
Citations
55373
World Ranking
13840
National Ranking
7

Research.com Recognitions

  • 2023 - Research.com Medicine in Czechia Leader Award
  • 2022 - Research.com Medicine in Czechia Leader Award

Overview

Karel Pavelka is affiliated with Charles University in the Czech Republic. Their research predominantly falls within the field of Medicine, with a focus on Rheumatology as well as Immunology, Pathology and Forensic Medicine, Epidemiology, and Psychiatry and Mental Health as subfields of study.

Their scholarly output includes significant engagement with topics such as Rheumatoid Arthritis Research and Therapies, Spondyloarthritis Studies and Treatments, Psoriasis: Treatment and Pathogenesis, Systemic Sclerosis and Related Diseases, Systemic Lupus Erythematosus Research, Fibromyalgia and Chronic Fatigue Syndrome Research, and Inflammatory Myopathies and Dermatomyositis.

Frequent coauthors contributing to the body of work alongside Pavelka include Ladislav Šenolt, Jiří Vencovský, Jakub Závada, Michal Tomčík, and Žiga Rotar, each reflecting collaborations across multiple projects.

They have published in several notable scientific venues, with repeated contributions to:

  • Annals of the Rheumatic Diseases
  • Lara D. Veeken
  • Scientific Reports
  • RMD Open
  • Arthritis Research & Therapy

Selected recent papers illustrate the scope and application of Pavelka's research:

  • "Plasma Hsp90 levels in patients with systemic sclerosis and relation to lung and skin involvement: a cross-sectional and longitudinal study" (2021, Scientific Reports)
  • "EULAR recommendations for the non-pharmacological core management of hip and knee osteoarthritis: 2023 update" (2024, Annals of the Rheumatic Diseases)
  • "Effectiveness of TNF-inhibitors, abatacept, IL6-inhibitors and JAK-inhibitors in 31 846 patients with rheumatoid arthritis in 19 registers from the 'JAK-pot' collaboration" (2022, Annals of the Rheumatic Diseases)
  • "The impact of seropositivity on the effectiveness of biologic anti-rheumatic agents: results from a collaboration of 16 registries" (2020, Lara D. Veeken)
  • "Drug retention, inactive disease and response rates in 1860 patients with axial spondyloarthritis initiating secukinumab treatment: routine care data from 13 registries in the EuroSpA collaboration" (2020, RMD Open)

Best Publications

  • EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update

    Josef S Smolen;Robert Landewé;Ferdinand C Breedveld;Maya Buch;Maya Buch

  • Plasma Hsp90 levels in patients with systemic sclerosis and relation to lung and skin involvement: a cross-sectional and longitudinal study.

    Hana Štorkánová;Sabína Oreská;Maja Špiritović;Barbora Heřmánková

  • Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: double-blind randomised controlled trial

    Lars Klareskog;Désirée van der Heijde;Julien P de Jager;Andrew Gough

  • The PREMIER study: A multicenter, randomized, double-blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had previous methotrexate treatment

    Ferdinand C Breedveld;Michael H Weisman;Arthur F Kavanaugh;Stanley B Cohen

  • EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs

    Josef S. Smolen;Robert Landewé;Ferdinand C Breedveld;Maxime Dougados

  • EULAR Recommendations 2003: an evidence based approach to the management of knee osteoarthritis: Report of a Task Force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT)

    K M Jordan;N K Arden;M Doherty;B Bannwarth

  • EULAR recommendations for the non-pharmacological core management of hip and knee osteoarthritis

    Linda Fernandes;Kåre B Hagen;Johannes W J Bijlsma;Oyvor Andreassen

  • 2010 update of the ASAS/EULAR recommendations for the management of ankylosing spondylitis

    J Braun;R van den Berg;X Baraliakos;H Boehm

  • Treatment of rheumatoid arthritis with recombinant human interleukin‐1 receptor antagonist

    Barry Bresnihan;José Maria Alvaro‐Gracia;Mark Cobby;Michael Doherty

  • EULAR evidence based recommendations for the management of hip osteoarthritis: report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT)

    W. Zhang;M. Doherty;B. F. Leeb;L. Alekseeva

  • Double-blind randomized controlled clinical trial of the interleukin-6 receptor antagonist, tocilizumab, in European patients with rheumatoid arthritis who had an incomplete response to methotrexate.

    R N Maini;P C Taylor;J Szechinski;K Pavelka

  • European League Against Rheumatism (EULAR) recommendations for the management of psoriatic arthritis with pharmacological therapies: 2015 update.

    L Gossec;J S Smolen;S Ramiro;M de Wit

  • ASAS/EULAR recommendations for the management of ankylosing spondylitis

    J. Zochling;D. Van Der Heijde;R. Burgos-Vargas;E. Collantes

  • Glucosamine sulfate use and delay of progression of knee osteoarthritis: a 3-year, randomized, placebo-controlled, double-blind study.

    Karel Pavelka;Jindriska Gatterova;Marta Olejarova;Stanislav Machacek

  • EULAR evidence-based recommendations for the diagnosis of knee osteoarthritis

    W Zhang;M Doherty;G Peat;S Ma Bierma-Zeinstra

  • Tocilizumab monotherapy versus adalimumab monotherapy for treatment of rheumatoid arthritis (ADACTA): a randomised, double-blind, controlled phase 4 trial

    Cem Gabay;Paul Emery;Ronald van Vollenhoven;Ara Dikranian

  • Certolizumab pegol plus methotrexate is significantly more effective than placebo plus methotrexate in active rheumatoid arthritis: findings of a fifty-two-week, phase III, multicenter, randomized, double-blind, placebo-controlled, parallel-group study.

    Edward Keystone;Désireé Van Der Heijde;David Mason;Robert Landewé

  • EULAR recommendations for the management of knee osteoarthritis: report of a task force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT)

    A Pendleton;N Arden;M Dougados;M Doherty

  • FRI0298 The Impact of DMARD Co-Therapy on Abatacept Effectiveness in Rheumatoid Arthritis Patients. A Pan-European Analysis of RA Registries

    A. Finckh;D. Neto;J. Gomez-Reino;F. Iannone

  • EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs

    J. S. Smolen;R. Landewé;F. C. Breedveld;M. Dougados

Frequent Co-Authors

Cem Gabay
Cem Gabay University of Geneva
Tore K. Kvien
Tore K. Kvien University of Oslo
Paul Emery
Paul Emery University of Leeds
Olivier Bruyère
Olivier Bruyère University of Liège
Maxime Dougados
Maxime Dougados Hôpital Cochin
Jean-Yves Reginster
Jean-Yves Reginster University of Liège
Xavier Mariette
Xavier Mariette University of Paris-Saclay
Michael T. Nurmohamed
Michael T. Nurmohamed University of Amsterdam
Ronald F. van Vollenhoven
Ronald F. van Vollenhoven University of Amsterdam
Josef S. Smolen
Josef S. Smolen Medical University of Vienna

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in healthcare careers beyond traditional medical school, numerous online degree options exist. Popular career pathways include nursing, healthcare administration, and advanced practice roles. Online programs offer the flexibility to balance study with work or family commitments.

Nurses looking to specialize in mental health can explore msn to pmhnp online programs, which provide a fast-track to becoming a Psychiatric Mental Health Nurse Practitioner. For those interested in the business and leadership side of healthcare, a healthcare administration degree cost breakdown helps identify programs that fit your budget.

Graduate degrees are also accessible online. If you’re seeking advanced management roles, consider an affordable mha online program. Aspiring to the highest nursing qualifications? The best online dnp programs prepare nurses for leadership, research, and clinical practice at the doctoral level.

Exploring these online degrees opens numerous pathways in medicine and healthcare, catering to diverse interests and career goals.

Best Scientists Citing Karel Pavelka

Trending Scientists